Roche: two new diagnostic tests for transplant patients
(CercleFinance.com) - Roche today announced the commercial availability of two tests for use on its cobas systems for transplant patients in countries accepting the CE mark.
The cobas EBV (Epstein-Barr virus) and cobas BKV (BK virus) tests are providing results that help healthcare professionals to assess if severely immuno-compromised transplant patients are at risk of developing disease by pathogens which could lead to organ rejection.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The cobas EBV (Epstein-Barr virus) and cobas BKV (BK virus) tests are providing results that help healthcare professionals to assess if severely immuno-compromised transplant patients are at risk of developing disease by pathogens which could lead to organ rejection.
Copyright (c) 2019 CercleFinance.com. All rights reserved.